Cadrenal Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for patients with chronic kidney disease and related disorders

The company is committed to advancing innovative treatment options that address unmet medical needs in the renal space, leveraging its expertise in drug development and research to create transformative solutions. Cadrenal aims to improve the quality of life for patients through its targeted approaches to disease management and therapeutic interventions, and is dedicated to clinical research that fosters a deeper understanding of kidney health.